Trial intelligence / Profile preview

Vitamin B6 for Depression and Anxiety Symptoms

NCT07469462Completed

Sponsor
University of Reading
Start
Mar 2026
Primary completion
Sep 2026
Countries
1
01

Overview

Randomised trial in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by University of Reading. Primary endpoint: Neural inhibition measured using Electroencephalography at 1 week. Started Mar 2026; status: completed.

02

Conditions

major depressive disorder (MDD)anxiety disorder

Beyond the preview

Go deeper on NCT07469462.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07469462.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call